Trump Says Pharma Tariffs May Be Pushed Back, But Could Be Enormous If/When They Do Arrive
Shares:
Look, there’s not much going on today, so I won’t waste your time with a lot of fluff. In the absence of actual news, I’m paying close attention to potential
The Wall Street Journal covered, with some depth, the trend of biosimilars launching with two prices: a low price designed to be appealing to consumers (and, I guess, media) and
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv